The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Acetic acid 2-{2-[(2-allylsulfanyl-6-phenylimidazo[2,1-b][1,3,4]thiadiazol-5-ylmethylene)hydrazono]-4-oxothiazolidin-5-yl}ethyl ester ID: ALA4524672
PubChem CID: 155538500
Max Phase: Preclinical
Molecular Formula: C21H20N6O3S3
Molecular Weight: 500.63
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C=CCSc1nn2c(/C=N/N=C3/NC(=O)C(CCOC(C)=O)S3)c(-c3ccccc3)nc2s1
Standard InChI: InChI=1S/C21H20N6O3S3/c1-3-11-31-21-26-27-15(17(23-20(27)33-21)14-7-5-4-6-8-14)12-22-25-19-24-18(29)16(32-19)9-10-30-13(2)28/h3-8,12,16H,1,9-11H2,2H3,(H,24,25,29)/b22-12+
Standard InChI Key: YULCKLSWLHFMQF-WSDLNYQXSA-N
Molfile:
RDKit 2D
33 36 0 0 0 0 0 0 0 0999 V2000
8.7074 -15.3861 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6891 -14.0479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2182 -14.7238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4799 -14.2922 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.4891 -15.1177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2772 -15.3669 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
10.7567 -14.6929 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2623 -14.0299 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3977 -14.7363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9736 -14.0251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1491 -14.0362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7476 -14.7577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1725 -15.4696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9956 -15.4550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4236 -13.2666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6138 -13.1079 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3483 -12.3267 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5384 -12.1680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1866 -11.4223 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3671 -11.5204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2084 -12.3303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9298 -12.7301 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.8085 -10.9143 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4591 -12.6756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7834 -12.2030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0384 -12.5483 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.3627 -12.0757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6134 -12.4210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4361 -11.2536 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.5779 -14.6839 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
11.9963 -15.3904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8175 -15.3813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2360 -16.0878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 5 2 0
4 2 1 0
2 3 2 0
3 1 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 4 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
3 9 1 0
2 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 18 1 0
20 23 2 0
21 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
27 29 2 0
7 30 1 0
30 31 1 0
31 32 1 0
32 33 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 500.63Molecular Weight (Monoisotopic): 500.0759AlogP: 3.61#Rotatable Bonds: 9Polar Surface Area: 110.31Molecular Species: NEUTRALHBA: 11HBD: 1#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 7.34CX Basic pKa: 1.67CX LogP: 4.20CX LogD: 3.87Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.16Np Likeness Score: -1.30
References 1. Kryshchyshyn A, Kaminskyy D, Karpenko O, Gzella A, Grellier P, Lesyk R.. (2019) Thiazolidinone/thiazole based hybrids - New class of antitrypanosomal agents., 174 [PMID:31051403 ] [10.1016/j.ejmech.2019.04.052 ] 2. Schadich E,Kryshchyshyn-Dylevych A,Holota S,Polishchuk P,Džubak P,Gurska S,Hajduch M,Lesyk R. (2020) Assessing different thiazolidine and thiazole based compounds as antileishmanial scaffolds., 30 (23.0): [PMID:33091607 ] [10.1016/j.bmcl.2020.127616 ]